NAFLD/MASLD

Clinical trials for NAFLD/MASLD explained in plain language.

Never miss a new study

Get alerted when new NAFLD/MASLD trials appear

Sign up with your email to follow new studies for NAFLD/MASLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial tests promising drug to reverse scarring in fatty liver disease

Disease control Ongoing

This large, late-stage study is testing whether a drug called efruxifermin is safe and effective for people with a serious form of fatty liver disease called NASH or MASH. About 700 adults with the disease will receive either the drug or a placebo for a period of time. The main g…

Matched conditions: NAFLD/MASLD

Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NAFLD/MASLD

Get alerted when new NAFLD/MASLD trials appear

Major trial tests promising drug to reverse scarring in fatty liver disease